6-30345475-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001199120.3(RPP21):c.167C>T(p.Ser56Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,610,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001199120.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPP21 | NM_024839.4 | c.159-16C>T | intron_variant | ENST00000442966.7 | NP_079115.1 | |||
RPP21 | NM_001199120.3 | c.167C>T | p.Ser56Phe | missense_variant | 3/5 | NP_001186049.1 | ||
TRIM39-RPP21 | NM_001199119.1 | c.1206-16C>T | intron_variant | NP_001186048.1 | ||||
RPP21 | NM_001199121.3 | c.159-16C>T | intron_variant | NP_001186050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPP21 | ENST00000442966.7 | c.159-16C>T | intron_variant | 1 | NM_024839.4 | ENSP00000403833.2 | ||||
TRIM39-RPP21 | ENST00000623385.3 | c.1206-16C>T | intron_variant | 5 | ENSP00000485378.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458054Hom.: 0 Cov.: 38 AF XY: 0.00000276 AC XY: 2AN XY: 725170
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.167C>T (p.S56F) alteration is located in exon 3 (coding exon 3) of the RPP21 gene. This alteration results from a C to T substitution at nucleotide position 167, causing the serine (S) at amino acid position 56 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at